Literature DB >> 22151942

Side effects and complications of fractional 1550-nm erbium fiber laser treatment among Asians.

Premjit Vaiyavatjamai1, Penpun Wattanakrai.   

Abstract

BACKGROUND: Fractional erbium fiber laser is an effective treatment for facial wrinkles, acne scars, and dyspigmentation available worldwide. However, there are minimal data of adverse events and complications in Asians.
OBJECTIVE: To determine safety and adverse events associated with fractional erbium laser treatment in Asian patients.
METHODS: Retrospective data of 181 fractional 1550-nm Ytterbium/Erbium fiber laser (Finescan(™) ; TNC Medditron Co., Ltd., Thailand) from 119 patients with skin phototype III-V at Ramathibodi Laser Center were reviewed. Patient demographics including gender, age, and dermatologic indications for treatment were assessed. Safety and adverse effects related to the treatment were identified.
RESULTS: Only six treatments (3.3%) developed complications. The most common adverse event was postinflammatory hyperpigmentation (2.2%), while acneiform eruption and desquamation were reported 0.55%, equally. Although none of the patients received herpes prophylaxis, there were no herpes outbreaks.
CONCLUSION: Fractional erbium laser treatment in Asian skin is quite safe, and the side effects in this study were relatively low. Herpes prophylaxis may not be required.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22151942     DOI: 10.1111/j.1473-2165.2011.00585.x

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  2 in total

1.  Combination of medical needling and non-cultured autologous skin cell transplantation (renovacell) for repigmentation of hypopigmented burn scars in children and young people.

Authors:  K H Busch; R Bender; N Walezko; H Aziz; M A Altintas; M C Aust
Journal:  Ann Burns Fire Disasters       Date:  2016-06-30

2.  A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Authors:  Maryam Nasimi; Maryam Ghiasi; Vahideh Lajevardi; Fatemeh Nasiri; Safoura Shakoei
Journal:  Arch Dermatol Res       Date:  2021-10-27       Impact factor: 3.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.